BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 30469488)

  • 1. Loss of Myeloid-Specific TGF-β Signaling Decreases CTHRC1 to Downregulate bFGF and the Development of H1993-Induced Osteolytic Bone Lesions.
    Ganguly SS; Daft PG; Cao J; Meng X; Zhong ZA; Vander Ark A; Meadows A; Madaj Z; Williams B; Li X
    Cancers (Basel); 2018 Nov; 10(12):. PubMed ID: 30469488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of TGF-β signaling in osteoblasts increases basic-FGF and promotes prostate cancer bone metastasis.
    Meng X; Vander Ark A; Daft P; Woodford E; Wang J; Madaj Z; Li X
    Cancer Lett; 2018 Apr; 418():109-118. PubMed ID: 29337106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloid-specific TGF-β signaling in bone promotes basic-FGF and breast cancer bone metastasis.
    Meng X; Vander Ark A; Lee P; Hostetter G; Bhowmick NA; Matrisian LM; Williams BO; Miranti CK; Li X
    Oncogene; 2016 May; 35(18):2370-8. PubMed ID: 26279296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of osteoclast differentiation and collagen antibody-induced arthritis by CTHRC1.
    Jin YR; Stohn JP; Wang Q; Nagano K; Baron R; Bouxsein ML; Rosen CJ; Adarichev VA; Lindner V
    Bone; 2017 Apr; 97():153-167. PubMed ID: 28115279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. WAIF1 Is a Cell-Surface CTHRC1 Binding Protein Coupling Bone Resorption and Formation.
    Matsuoka K; Kohara Y; Naoe Y; Watanabe A; Ito M; Ikeda K; Takeshita S
    J Bone Miner Res; 2018 Aug; 33(8):1500-1512. PubMed ID: 29624737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wenshen Zhuanggu formula mitigates breast cancer bone metastasis through the signaling crosstalk among the Jagged1/Notch, TGF-β and IL-6 signaling pathways.
    Wu C; Chen M; Sun Z; Ye Y; Han X; Qin Y; Liu S
    J Ethnopharmacol; 2019 Mar; 232():145-154. PubMed ID: 30576770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wnt signaling induces gene expression of factors associated with bone destruction in lung and breast cancer.
    Johnson RW; Merkel AR; Page JM; Ruppender NS; Guelcher SA; Sterling JA
    Clin Exp Metastasis; 2014 Dec; 31(8):945-59. PubMed ID: 25359619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autocrine CTHRC1 activates hepatic stellate cells and promotes liver fibrosis by activating TGF-β signaling.
    Li J; Wang Y; Ma M; Jiang S; Zhang X; Zhang Y; Yang X; Xu C; Tian G; Li Q; Wang Y; Zhu L; Nie H; Feng M; Xia Q; Gu J; Xu Q; Zhang Z
    EBioMedicine; 2019 Feb; 40():43-55. PubMed ID: 30639416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene Modification of Transforming Growth Factor β (TGF-β) and Interleukin 10 (IL-10) in Suppressing Mt Sonicate Induced Osteoclast Formation and Bone Absorption.
    Yi L; Li Z; Jiang H; Cao Z; Liu J; Zhang X
    Med Sci Monit; 2018 Jul; 24():5200-5207. PubMed ID: 30050032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early TGF-β inhibition in mice reduces the incidence of breast cancer induced bone disease in a myeloid dependent manner.
    Buenrostro D; Kwakwa KA; Putnam NE; Merkel AR; Johnson JR; Cassat JE; Sterling JA
    Bone; 2018 Aug; 113():77-88. PubMed ID: 29753718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acceleration of bone regeneration by local application of lithium: Wnt signal-mediated osteoblastogenesis and Wnt signal-independent suppression of osteoclastogenesis.
    Arioka M; Takahashi-Yanaga F; Sasaki M; Yoshihara T; Morimoto S; Hirata M; Mori Y; Sasaguri T
    Biochem Pharmacol; 2014 Aug; 90(4):397-405. PubMed ID: 24955980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wedelolactone enhances osteoblastogenesis by regulating Wnt/β-catenin signaling pathway but suppresses osteoclastogenesis by NF-κB/c-fos/NFATc1 pathway.
    Liu YQ; Hong ZL; Zhan LB; Chu HY; Zhang XZ; Li GH
    Sci Rep; 2016 Aug; 6():32260. PubMed ID: 27558652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DOK3 Modulates Bone Remodeling by Negatively Regulating Osteoclastogenesis and Positively Regulating Osteoblastogenesis.
    Cai X; Xing J; Long CL; Peng Q; Humphrey MB
    J Bone Miner Res; 2017 Nov; 32(11):2207-2218. PubMed ID: 28650106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CTHRC1 promotes human colorectal cancer cell proliferation and invasiveness by activating Wnt/PCP signaling.
    Yang XM; You HY; Li Q; Ma H; Wang YH; Zhang YL; Zhu L; Nie HZ; Qin WX; Zhang ZG; Li J
    Int J Clin Exp Pathol; 2015; 8(10):12793-801. PubMed ID: 26722469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of OPG-deficient mice with WP9QY, a RANKL-binding peptide, recovers alveolar bone loss by suppressing osteoclastogenesis and enhancing osteoblastogenesis.
    Ozaki Y; Koide M; Furuya Y; Ninomiya T; Yasuda H; Nakamura M; Kobayashi Y; Takahashi N; Yoshinari N; Udagawa N
    PLoS One; 2017; 12(9):e0184904. PubMed ID: 28937990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteoclast TGF-β Receptor Signaling Induces Wnt1 Secretion and Couples Bone Resorption to Bone Formation.
    Weivoda MM; Ruan M; Pederson L; Hachfeld C; Davey RA; Zajac JD; Westendorf JJ; Khosla S; Oursler MJ
    J Bone Miner Res; 2016 Jan; 31(1):76-85. PubMed ID: 26108893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postnatal deletion of β-catenin in osterix-expressing cells is necessary for bone growth and intermittent PTH-induced bone gain.
    Yu C; Xuan M; Zhang M; Yao Q; Zhang K; Zhang X; Guo J; Song L
    J Bone Miner Metab; 2018 Sep; 36(5):560-572. PubMed ID: 29124436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies in cranial suture biology: up-regulation of transforming growth factor-beta1 and basic fibroblast growth factor mRNA correlates with posterior frontal cranial suture fusion in the rat.
    Most D; Levine JP; Chang J; Sung J; McCarthy JG; Schendel SA; Longaker MT
    Plast Reconstr Surg; 1998 May; 101(6):1431-40. PubMed ID: 9583470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor beta affects osteoclast differentiation via direct and indirect actions.
    Quinn JM; Itoh K; Udagawa N; Hausler K; Yasuda H; Shima N; Mizuno A; Higashio K; Takahashi N; Suda T; Martin TJ; Gillespie MT
    J Bone Miner Res; 2001 Oct; 16(10):1787-94. PubMed ID: 11585342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sema3A Inhibits Osteolytic Bone Metastasis of Non-small Cell Lung Cancer.
    Wang W; Shen K; Liu R; Zhou Q
    Recent Pat Anticancer Drug Discov; 2024 Apr; ():. PubMed ID: 38629364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.